RDD Blog » cancer

R&D Directions Insider

Archive for the ‘ cancer ’ Category

Regulatory minds meet in Philly

Tuesday, September 15th, 2009

Â The City of Brotherly Love is the site of this week's Regulatory Affairs Professionals Society'sÂ 2009 Annual Conference & Exhibition. With much change afoot these days at FDA and healthcare reform dominating the American consciousness (more on that later), it's no surprise the theme for this year's event is "Succeed in ...

Posted in Uncategorized, animals, cancer, clinical trials, vaccines | No Comments »

Researchers dig ‘hedgehog’ data

Friday, September 4th, 2009

Next month, R&D Directions will feature the magazineâ€™s 9th annual report on the top 10 areas of research. But first, of course, we must do our own research on what exactly it is researchers are researching these days. That requires, for yours truly, a fair amount of news digging and brain ...

Posted in animals, cancer, clinical trials, plants | No Comments »

“Trojan horse” goes cellular to attack cancer, diabetes, infections

Monday, June 29th, 2009

With biotechnology companies looking to control RNA to block genes that produce disease-causing proteins involved in cancer and other diseases, a new study shows that researchers may be one step closer using the â€œTrojan horseâ€ method. The therapy uses bacterially derived nano cells that may directly target cancer cells with chemotherapy ...

Posted in cancer | No Comments »

Diabetes studies offer cancer clues

Thursday, June 4th, 2009

Researchers have made a breakthrough that may increase the efficiency of vaccines and cancer treatments. They discovered that diabetes drug metformin can increase T-cellâ€™s in the bodyâ€™s immune system and since T-cells can remember pathogens they have encountered from past infections of vaccinations they can fight infections faster. DiabetesÂ therapies are ...

Posted in cancer, diabetes, vaccines | No Comments »

CROs converge in Disney

Tuesday, April 28th, 2009

Close enough, at least. Orlandoâ€™s Rosen Shingle Creek Hotel, the site of this weekâ€™s 18th Annual Partnerships with CROs conference, is just a wand's throw from Magic Kingdom. I know this, because I see a big roller coaster off in the distance outside my hotel window. Or maybe thatâ€™s part ...

Posted in Uncategorized, cancer | No Comments »

New trial cuts drug development time

Friday, April 17th, 2009

In an effort to speed up drug development, scientists have come up with the Phase 0 clinical trial. Phase 0 studies would cut down on the cost and lengthy drug development process, providing faster drug delivery to patients. Less patients are also needed in Phase 0 trials, about 10-12, compared ...

Posted in cancer, clinical trials | No Comments »

Old MacDonald’s Pharma: Part 3

Friday, March 6th, 2009

Goats, llamas, and now chickens According to FierceBiotech, Symphogen and Origen Therapeutics are teaming up to develop a transgenic chicken that can produce recombinant human antibodies against cancer, infectious diseases, and autoimmune diseases. The chickens will be used as a live breeding ground for more complex antibody development, which is believed ...

Posted in animals, antibodies, cancer, infectious diseases, transgenics | No Comments »

Old MacDonald’s Pharma: Part 2

Wednesday, February 18th, 2009

Goats are not the only animals being used to develop new drugs. As The Wall Street JournalÂ reported on Tuesday, llamas are being used to discover treatments for diseases such as rheumatoid arthritis, cancer, and Alzheimerâ€™s disease. These pack animals and their relatives- camels and alpacas, naturally create very small antibodies ...

Posted in animals, antibodies, cancer | 1 Comment »

©2012 UBM Canon